174 related articles for article (PubMed ID: 29335904)
1. The SAFE pathway for cardioprotection: is this a promising target?
Hadebe N; Cour M; Lecour S
Basic Res Cardiol; 2018 Jan; 113(2):9. PubMed ID: 29335904
[TBL] [Abstract][Full Text] [Related]
2. Role of toll-like receptor 4 in melatonin-induced cardioprotection.
Nduhirabandi F; Lamont K; Albertyn Z; Opie LH; Lecour S
J Pineal Res; 2016 Jan; 60(1):39-47. PubMed ID: 26465095
[TBL] [Abstract][Full Text] [Related]
3. Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway.
Lacerda L; Somers S; Opie LH; Lecour S
Cardiovasc Res; 2009 Nov; 84(2):201-8. PubMed ID: 19666677
[TBL] [Abstract][Full Text] [Related]
4. HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity.
Frias MA; Pedretti S; Hacking D; Somers S; Lacerda L; Opie LH; James RW; Lecour S
Atherosclerosis; 2013 May; 228(1):110-6. PubMed ID: 23497785
[TBL] [Abstract][Full Text] [Related]
5. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291
[TBL] [Abstract][Full Text] [Related]
6. No risk, no ... cardioprotection? A critical perspective.
Heusch G
Cardiovasc Res; 2009 Nov; 84(2):173-5. PubMed ID: 19713282
[No Abstract] [Full Text] [Related]
7. Interleukin-22 Directly Activates Myocardial STAT3 (Signal Transducer and Activator of Transcription-3) Signaling Pathway and Prevents Myocardial Ischemia Reperfusion Injury.
Takahashi J; Yamamoto M; Yasukawa H; Nohara S; Nagata T; Shimozono K; Yanai T; Sasaki T; Okabe K; Shibata T; Mawatari K; Kakuma T; Aoki H; Fukumoto Y
J Am Heart Assoc; 2020 Apr; 9(8):e014814. PubMed ID: 32301368
[TBL] [Abstract][Full Text] [Related]
8. Shining the spotlight on cardioprotection: beyond the cardiomyocyte.
Davidson SM; Andreadou I; Garcia-Dorado D; Hausenloy DJ
Cardiovasc Res; 2019 Jun; 115(7):1115-1116. PubMed ID: 30865272
[No Abstract] [Full Text] [Related]
9. Mitochondrial bioenergetics and cardiolipin alterations in myocardial ischemia-reperfusion injury: implications for pharmacological cardioprotection.
Paradies G; Paradies V; Ruggiero FM; Petrosillo G
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1341-H1352. PubMed ID: 30095969
[TBL] [Abstract][Full Text] [Related]
10. Heat shock protein 70: A promising therapeutic target for myocardial ischemia-reperfusion injury.
Song YJ; Zhong CB; Wang XB
J Cell Physiol; 2019 Feb; 234(2):1190-1207. PubMed ID: 30132875
[TBL] [Abstract][Full Text] [Related]
11. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC
J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692
[TBL] [Abstract][Full Text] [Related]
12. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats.
Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG
Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894
[TBL] [Abstract][Full Text] [Related]
13. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?
Lecour S
J Mol Cell Cardiol; 2009 Jul; 47(1):32-40. PubMed ID: 19344728
[TBL] [Abstract][Full Text] [Related]
14. Nitrite-Nitric Oxide Signaling and Cardioprotection.
Totzeck M; Hendgen-Cotta UB; Rassaf T
Adv Exp Med Biol; 2017; 982():335-346. PubMed ID: 28551796
[TBL] [Abstract][Full Text] [Related]
15. Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists.
Maslov LN; Khaliulin I; Zhang Y; Krylatov AV; Naryzhnaya NV; Mechoulam R; De Petrocellis L; Downey JM
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):262-72. PubMed ID: 26487546
[TBL] [Abstract][Full Text] [Related]
16. Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.
Russell J; Du Toit EF; Peart JN; Patel HH; Headrick JP
Cardiovasc Diabetol; 2017 Dec; 16(1):155. PubMed ID: 29202762
[TBL] [Abstract][Full Text] [Related]
17. Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin.
Hausenloy DJ; Lecour S; Yellon DM
Antioxid Redox Signal; 2011 Mar; 14(5):893-907. PubMed ID: 20615076
[TBL] [Abstract][Full Text] [Related]
18. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
[TBL] [Abstract][Full Text] [Related]
19. The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway.
Duan W; Yang Y; Yan J; Yu S; Liu J; Zhou J; Zhang J; Jin Z; Yi D
Basic Res Cardiol; 2012 May; 107(3):263. PubMed ID: 22466958
[TBL] [Abstract][Full Text] [Related]
20. A novel therapeutic peptide targeting myocardial reperfusion injury.
Boisguérin P; Covinhes A; Gallot L; Barrère C; Vincent A; Busson M; Piot C; Nargeot J; Lebleu B; Barrère-Lemaire S
Cardiovasc Res; 2020 Mar; 116(3):633-644. PubMed ID: 31147690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
